{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:36:02Z","timestamp":1792704962672,"version":"4.5.0"},"reference-count":51,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Gut microbiota can contribute to the development and progression of non-alcoholic fatty liver disease (NAFLD). In fact, some specific changes of gut microbiota are observed in patients in what is called dysbiota. There has been a lot of investigation by using a variety of interventions, including diet, showing the possibility to modify components of gastrointestinal dysbiota towards healthy and multivariate microbiota to restore physiologic status. One of the main focuses has been dietary fiber (DF), in which most of its variants are prebiotics. The highest effective treatment for NAFLD is, so far, weight loss achieved by caloric restriction. DF supplementation with oligofructose facilitates weight loss, enhances the production of beneficial metabolites, decreases some pathogenic bacteria population by increasing Bifidobacteria, and has effects on intestinal barrier permeability. DF use has been associated with improvement in diverse metabolic diseases, including NAFLD, by modifying gut microbiota. Additionally, it has been shown that a higher insoluble fiber consumption (\u22657.5 g\/day) revealed improvements in 3 different scores of liver fibrosis. Further research is needed, but given the evidence available, it is reasonable to prescribe its consumption in early stages of NAFLD in order to prevent disease progression.<\/jats:p>","DOI":"10.3390\/nu12103100","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T22:02:02Z","timestamp":1602626522000},"page":"3100","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Microbiota, Fiber, and NAFLD: Is There Any Connection?"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8807-1935","authenticated-orcid":false,"given":"Alejandra","family":"P\u00e9rez-Montes de Oca","sequence":"first","affiliation":[{"name":"Endocrine and Nutrition Service, Germans Trias i Pujol Hospital and Research Institute, Universitat Aut\u00f2noma de Barcelona, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Juli\u00e1n","sequence":"additional","affiliation":[{"name":"Endocrine and Nutrition Service, Germans Trias i Pujol Hospital and Research Institute, Universitat Aut\u00f2noma de Barcelona, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0882-1247","authenticated-orcid":false,"given":"Anal\u00eda","family":"Ramos","sequence":"additional","affiliation":[{"name":"Endocrine and Nutrition Service, Germans Trias i Pujol Hospital and Research Institute, Universitat Aut\u00f2noma de Barcelona, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Puig-Domingo","sequence":"additional","affiliation":[{"name":"Endocrine and Nutrition Service, Germans Trias i Pujol Hospital and Research Institute, Universitat Aut\u00f2noma de Barcelona, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Alonso","sequence":"additional","affiliation":[{"name":"Endocrine and Nutrition Service, Germans Trias i Pujol Hospital and Research Institute, Universitat Aut\u00f2noma de Barcelona, 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic Fatty Liver Disease Is Independently Associated with an Increased Incidence of Cardiovascular Events in Type 2 Diabetic Patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-nutr-070208-114232","article-title":"Nonalcoholic Fatty Liver Disease and Low-Carbohydrate Diets","volume":"29","author":"York","year":"2009","journal-title":"Annu. Rev. Nutr."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL) (2016). EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease. Diabetologia, 59, 1121\u20131140.","DOI":"10.1007\/s00125-016-3902-y"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s10620-014-3380-3","article-title":"Total Body Weight Loss of \u226510% Is Associated with Improved Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis","volume":"60","author":"Glass","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cld.2015.10.008","article-title":"Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease","volume":"20","author":"Hannah","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/hep.24242","article-title":"Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects","volume":"53","author":"Haufe","year":"2011","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Mills, S., Stanton, C., Lane, J.A., Smith, G.J., and Ross, R.P. (2019). Precision Nutrition and the Microbiome, Part I: Current State of the Science. Nutrients, 11.","DOI":"10.3390\/nu11040923"},{"key":"ref_11","first-page":"82","article-title":"A review of gastrointestinal physiology and the mechanisms underlying the health benefits of dietary fiber: Matching an effective fiber with specific patient needs","volume":"1","author":"McRorie","year":"2013","journal-title":"Clin. Nurs. Stud."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Williams, B.A., Grant, L.J., Gidley, M.J., and Mikkelsen, D. (2017). Gut Fermentation of Dietary Fibres: Physico-Chemistry of Plant Cell Walls and Implications for Health. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102203"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Yang, Q., Liang, Q., Balakrishnan, B., Belobrajdic, D.P., Feng, Q.-J., and Zhang, W. (2020). Role of Dietary Nutrients in the Modulation of Gut Microbiota: A Narrative Review. Nutrients, 12.","DOI":"10.3390\/nu12020381"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13073-015-0157-z","article-title":"The gut microbiome in cardio-metabolic health","volume":"7","author":"Hansen","year":"2015","journal-title":"Genome Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4161\/gmic.19625","article-title":"Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity","volume":"3","author":"Cani","year":"2012","journal-title":"Gut Microbes"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Krawczyk, M., Maciejewska, D., Ryterska, K., Czerwi\u0144ka-Rogowska, M., Jamio\u0142-Milc, D., Skonieczna-\u017bydecka, K., Milkiewicz, P., Raszeja-Wyszomirska, J., and Stachowska, E. (2018). Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction. Nutrients, 10.","DOI":"10.3390\/nu10111793"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"nzy005","DOI":"10.1093\/cdn\/nzy005","article-title":"Health Effects and Sources of Prebiotic Dietary Fiber","volume":"2","author":"Carlson","year":"2018","journal-title":"Curr. Dev. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3920\/BM2012.0065","article-title":"Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: Novel insights into molecular targets and interventions using prebiotics","volume":"5","author":"Geurts","year":"2014","journal-title":"Benef. Microbes"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.3390\/nu7115454","article-title":"Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance","volume":"7","year":"2015","journal-title":"Nutrients"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1177\/0148607111413772","article-title":"Gut Microbiota, Intestinal Permeability, Obesity-Induced Inflammation, and Liver Injury","volume":"35","author":"Frazier","year":"2011","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Poeta, M., Pierri, L., and Vajro, P. (2017). Gut\u2013Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease. Children, 4.","DOI":"10.3390\/children4080066"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cgh.2013.02.015","article-title":"Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans with Nonalcoholic Fatty Liver Disease","volume":"11","author":"Raman","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_23","first-page":"srep08096","article-title":"Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.26319","article-title":"Intestinal microbiota in patients with nonalcoholic fatty liver disease","volume":"58","author":"Mouzaki","year":"2013","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Hiippala, K., Jouhten, H., Ronkainen, A., Hartikainen, A., Kainulainen, V., Jalanka, J., and Satokari, R. (2018). The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation. Nutrients, 10.","DOI":"10.3390\/nu10080988"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.numecd.2017.10.014","article-title":"Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study","volume":"28","author":"Duarte","year":"2018","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","article-title":"Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae","volume":"30","author":"Yuan","year":"2019","journal-title":"Cell Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.aohep.2019.04.006","article-title":"Microbiota and nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis (NAFLD\/NASH)","volume":"18","author":"Duarte","year":"2019","journal-title":"Ann. Hepatol."},{"key":"ref_30","first-page":"8","article-title":"Scientific Opinion on Dietary Reference Values for carbohydrates and dietary fibre","volume":"8","author":"Products","year":"2010","journal-title":"EFSA J."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Davani-Davari, D., Negahdaripour, M., Karimzadeh, I., Seifan, M., Mohkam, M., Masoumi, S.J., Berenjian, A., and Ghasemi, Y. (2019). Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods, 8.","DOI":"10.3390\/foods8030092"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Perdomo, C.M., Fr\u00fchbeck, G., and Escalada, J. (2019). Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease. Nutrients, 11.","DOI":"10.3390\/nu11030677"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1017\/S0007114516001045","article-title":"Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet","volume":"116","author":"Candela","year":"2016","journal-title":"Br. J. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Hald, S., Schioldan, A.G., Moore, M.E., Dige, A., L\u00e6rke, H.N., Agnholt, J., Knudsen, K.E.B., Hermansen, K., Marco, M.L., and Gregersen, S. (2016). Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159223"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1478-3231.2011.02730.x","article-title":"The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance","volume":"32","author":"Parnell","year":"2011","journal-title":"Liver Int."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Solah, V., Kerr, D.A., Hunt, W., Johnson, S., Boushey, C.J., Delp, E.J., Meng, X., Gahler, R.J., James, A.P., and Mukhtar, S.A. (2017). Effect of Fibre Supplementation on Body Weight and Composition, Frequency of Eating and Dietary Choice in Overweight Individuals. Nutrients, 9.","DOI":"10.3390\/nu9020149"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3945\/ajcn.2009.27465","article-title":"Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults","volume":"89","author":"Parnell","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_38","first-page":"7588","article-title":"Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era","volume":"22","author":"Ferrarese","year":"2018","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Cantero, I., Abete, I., Monreal, J.I., Martinez, J.A., and Zulet, M.A. (2017). Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction. Nutrients, 9.","DOI":"10.3390\/nu9070667"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1055\/a-0668-2891","article-title":"Vergleich einer kommerziell erh\u00e4ltlichen, Formula-basierten, mit Haferballaststoffen angereicherten Ern\u00e4hrungstherapie mit einer isokalorischen di\u00e4tetischen Therapie ohne Formula zur Therapie der nicht-alkoholischen Fettlebererkrankung (NAFLD) eine randomisierte, kontrollierte Interventionsstudie","volume":"56","author":"Schweinlin","year":"2018","journal-title":"Z. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1017\/S0007114514001421","article-title":"Beneficial effects of soluble dietary Jerusalem artichoke (Helianthus tuberosus) in the prevention of the onset of type 2 diabetes and non-alcoholic fatty liver disease in high-fructose diet-fed rats","volume":"112","author":"Chang","year":"2014","journal-title":"Br. J. Nutr."},{"key":"ref_42","first-page":"211","article-title":"Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development","volume":"4","author":"Stice","year":"2018","journal-title":"Chronic Dis. Transl. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Yamazaki, T., Li, D., and Ikaga, R. (2018). Effective Food Ingredients for Fatty Liver: Soy Protein \u03b2-Conglycinin and Fish Oil. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19124107"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Eslamparast, T., Tandon, P., and Raman, M. (2017). Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease. Nutrients, 9.","DOI":"10.3390\/nu9080800"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e3887","DOI":"10.1097\/MD.0000000000003887","article-title":"Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern","volume":"95","author":"Wehmeyer","year":"2016","journal-title":"Medicine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Trenell","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/jn\/nxz147","article-title":"A Mediterranean Diet Rich in Extra-Virgin Olive Oil Is Associated with a Reduced Prevalence of Nonalcoholic Fatty Liver Disease in Older Individuals at High Cardiovascular Risk","volume":"149","author":"Corbella","year":"2019","journal-title":"J. Nutr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1590\/S0004-28032007000400013","article-title":"Fibras sol\u00faveis no tratamento da doen\u00e7a hep\u00e1tica gordurosa n\u00e3o-alco\u00f3lica: Estudo piloto","volume":"44","author":"Rocha","year":"2007","journal-title":"Arq. Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2337\/dc12-0033","article-title":"Liver Fat Is Reduced by an Isoenergetic MUFA Diet in a Controlled Randomized Study in Type 2 Diabetic Patients","volume":"35","author":"Bozzetto","year":"2012","journal-title":"Diabetes Care"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/10\/3100\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:19:28Z","timestamp":1760177968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/10\/3100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["nu12103100"],"URL":"https:\/\/doi.org\/10.3390\/nu12103100","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]}}}